VEGFA and hepatocellular carcinoma: Regarding HCC angiogenesis, arenobufagin inhibited VEGF-induced viability, migration, invasion, and tube formation in HUVECs in vitro and suppressed sprouting formation from VEGF-treated aortic rings in an ex vivo model [25].